J&J’s Wu On Nurturing Innovation In Asia
Executive Summary
Dong Wu, head of J&J Innovation, Asia Pacific, outlines to Scrip the group’s partnering approach in South Korea and the Asia Pacific in general. He also offers some tips to Korean companies that are keen to pursue global partnerships.
You may also be interested in...
Big Pharma’s Partnering Process: An Insight Into The Nitty-Gritty
Amid ongoing interest in accessing innovative assets, including those from South Korea, big pharma participants at a recent symposium in Seoul shared the ins and outs of the complex partnering process.
AI Healthcare, Medical Devices Shine In Korea Q1 Financings
After the financing draught suffered by Korean bioventures in 2023, it now seems the VC market is poised for a recovery as investors shift attention again to the healthcare sector, with a spotlight on AI-based solutions and device firms.
Window Of Opportunity: Korea Unveils Cutting-Edge Bio Initiative
South Korea is moving forward with plan to set up a Boston-type biotech cluster in Osong as part of a broader initiative unveiled by President Yoon, while the biopharma industry is calling for rapid process, exceptional support.